Locations
Austin, TX, USA · Hamilton, ON, Canada · West University, Austin, TX, USA · Mt Hamilton, CA, USA
industry
Biotechnology · Biotechnology Research · Clinical Trials · Health Care
Size
11 - 50 employees
Stage
Series A
founded in
2015
Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Their proprietary T cell Antigen Coupler (TAC) technology recruits the entire natural T cell receptor and is independent of the major histocompatibility complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies and also with diseases other than cancer.
Something looks off?